AAX Biotech

AAX Biotech

Pre-clinical
Stockholm, SwedenFounded 2016aaxbiotech.com

AAX Biotech is committed to advancing next-generation therapies for a range of diseases. With a focus on antibody-based medicines, our proprietary technologies aim to solve key challenges in drug development. Our vision is to build a world-class antibody innovation engine — creating and advancing next-generation therapeutics building partnerships with top-tier pharma.

Founded
2016
Focus
Antibodies

About

AAX Biotech is committed to advancing next-generation therapies for a range of diseases. With a focus on antibody-based medicines, our proprietary technologies aim to solve key challenges in drug development. Our vision is to build a world-class antibody innovation engine — creating and advancing next-generation therapeutics building partnerships with top-tier pharma.

Funding History

1

Total raised: $2.5M

Seed$2.5MUndisclosedJun 15, 2021

Company Info

TypePrivate
Founded2016
LocationStockholm, Sweden
StagePre-clinical
SIMILAR COMPANIES
Basic Genomics
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
2A Pharma
Phase 1 · Stockholm
Abliva
Abliva
Pre-clinical · Lund
Affibody
Affibody
Phase 1 · Solna
Alligator Bioscience
Alligator Bioscience
Phase 1 · Lund
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile